Apocynin Decreases Cardiac Cytokines in STZ - Induced Diabetic Cardiomyopathy

E SHEN,Rui-zhen CHEN,Ying-zhen YANG,Hao-zhu CHEN
DOI: https://doi.org/10.3321/j.issn:1000-4718.2009.11.006
2009-01-01
Abstract:AIM: This study was to investigate the effects of apocynin on the expression of IL - 1β, IL - 18, TNF -α and COX -2 mRNA in the diabetic caidiomyopathy heart. METHODS: Diabetes was induced in 8 - week old C57 mice with one intraperitoneal injection of streptozotocin (STZ, 100 mg/kg). The experiments were divided into 4 groups; sham (n =6) , apocynin control (Apo, n=6) , diabetic cardiomyopathy (STZ, n = 16) and apocynin treatment (STZ + Apo, n= 16). At the end of 8 weeks after induction of diabetes, cardiac functions were evaluated by echocardio-graphy. Cardiac tissue was analyzed for the expression of IL - 1β, IL - 18, TNF - α, COX - 2 mRNA and phosphorylated Akt by real - time RT - PCR and Western blotting, respectively. RESULTS: The expression of IL - 1β, IL -18, TNF - α and COX - 2 mRNA increased in diabetic cardiomyopathy heart accompanied with cardiac dysfunction. Cardiac functions were improved with decreased levels of IL - 1β, IL - 18, TNF - α and COX - 2 mRNA expression in apocynin - treated heart. Compared with reduction of phosphorylated Akt, apocynin significantly increased phosphorylation of Akt in diabetic cardiomyopathy heart. CONCLUSION: Apocynin decreases cardiac IL - 1β, IL - 18, TNF - α and COX - 2 mRNA expression accompanied with improved cardiac function, which associates with the increase of phosphorylated Akt in diabetic cardiomyopathy heart.
What problem does this paper attempt to address?